Thu, October 11, 2018
Wed, October 10, 2018
Tue, October 9, 2018

Tazeen Ahmad Maintained (ACAD) at Strong Buy with Increased Target to $25 on, Oct 10th, 2018

Tazeen Ahmad of B of A Securities, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy with Increased Target from $22 to $25 on, Oct 10th, 2018.

Tazeen has made no other calls on ACAD in the last 4 months.



There are 3 other peers that have a rating on ACAD. Out of the 3 peers that are also analyzing ACAD, 1 agrees with Tazeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matteis Paul of "Stifel" Maintained at Hold with Decreased Target to $14 on, Thursday, August 9th, 2018


These are the ratings of the 2 analyists that currently disagree with Tazeen


  • Charles Duncan of "Cantor Fitzgerald" Initiated at Buy and Held Target at $25 on, Thursday, August 23rd, 2018
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $27 on, Thursday, August 9th, 2018